. First-line (1L) avelumab treatment in patients (pts) with metastatic Merkel cell carcinoma (mMCC): preliminary data from an ongoing study

Guilherme Rabinowits

Research output: Contribution to conference › Presentation

Original languageAmerican English
StatePublished - 2017
Event2017 ASCO annual meeting - Chicago, IL
Duration: Jan 1 2017 → …

Conference

Conference2017 ASCO annual meeting
Period1/1/17 → …

Disciplines

  • Medicine and Health Sciences

Cite this